Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef M Penninger

Showing results (371-380 of 457) with videos related to

Pageof 46
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2017
Glycogen Synthase Kinase-3 Modulates Cbl-b and Constrains T Cell ActivationCharles W Tran, Samuel D Saibil, Thierry Le Bihan, et al.
Nature Communications|February 16, 2024
A microfluidic platform integrating functional vascularized organoids-on-chipClément Quintard, Emily Tubbs, Gustav Jonsson, et al.
Cell Death & Disease|August 30, 2025
Targeting DDX3X suppresses progression of KRAS-driven lung cancer by disrupting antioxidative homeostasis and inducing ferroptosisMeijuan Dian, Liang Yun, Qingyu Meng, et al.
Cell|October 16, 2012
Hedgehog partial agonism drives Warburg-like metabolism in muscle and brown fatRaffaele Teperino, Sabine Amann, Martina Bayer, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2025
The RANK/RANKL axis controls vascular dynamics in the bone marrowTakeshi Kaneko, Shinya Yari, Junichi Kikuta, et al.
Science Translational Medicine|August 31, 2022
Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancerShane J F Cronin, Shuan Rao, Miguel A Tejada, et al.
Plos Genetics|October 17, 2018
A genome-wide Drosophila epithelial tumorigenesis screen identifies Tetraspanin 29Fb as an evolutionarily conserved suppressor of Ras-driven cancerTamara Zoranovic, Jan Manent, Lee Willoughby, et al.
Oncotarget|December 22, 2016
Aberrant regulation of RANKL/OPG in women at high risk of developing breast cancerStefan Kiechl, Daniel Schramek, Martin Widschwendter, et al.
Biorxiv : the Preprint Server for Biology|September 21, 2021
Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variantsGerald Wirnsberger, Vanessa Monteil, Brett Eaton, et al.
Cell|January 17, 2002
DREAM is a critical transcriptional repressor for pain modulationHai-Ying M Cheng, Graham M Pitcher, Steven R Laviolette, et al.
Pageof 46

Showing results (371-380 of 457) with videos related to

Sort By:
Pageof 46
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2017
Glycogen Synthase Kinase-3 Modulates Cbl-b and Constrains T Cell ActivationCharles W Tran, Samuel D Saibil, Thierry Le Bihan, et al.
Nature Communications|February 16, 2024
A microfluidic platform integrating functional vascularized organoids-on-chipClément Quintard, Emily Tubbs, Gustav Jonsson, et al.
Cell Death & Disease|August 30, 2025
Targeting DDX3X suppresses progression of KRAS-driven lung cancer by disrupting antioxidative homeostasis and inducing ferroptosisMeijuan Dian, Liang Yun, Qingyu Meng, et al.
Cell|October 16, 2012
Hedgehog partial agonism drives Warburg-like metabolism in muscle and brown fatRaffaele Teperino, Sabine Amann, Martina Bayer, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2025
The RANK/RANKL axis controls vascular dynamics in the bone marrowTakeshi Kaneko, Shinya Yari, Junichi Kikuta, et al.
Science Translational Medicine|August 31, 2022
Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancerShane J F Cronin, Shuan Rao, Miguel A Tejada, et al.
Plos Genetics|October 17, 2018
A genome-wide Drosophila epithelial tumorigenesis screen identifies Tetraspanin 29Fb as an evolutionarily conserved suppressor of Ras-driven cancerTamara Zoranovic, Jan Manent, Lee Willoughby, et al.
Oncotarget|December 22, 2016
Aberrant regulation of RANKL/OPG in women at high risk of developing breast cancerStefan Kiechl, Daniel Schramek, Martin Widschwendter, et al.
Biorxiv : the Preprint Server for Biology|September 21, 2021
Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variantsGerald Wirnsberger, Vanessa Monteil, Brett Eaton, et al.
Cell|January 17, 2002
DREAM is a critical transcriptional repressor for pain modulationHai-Ying M Cheng, Graham M Pitcher, Steven R Laviolette, et al.
Pageof 46